Overall Technical outlook

Price Summary

2026-04-30, saw AJANTPHARM's stock open at 2790.0, hit a peak of 2843.8, fall to a low of 2790.0, and close higher 1.17% at 2822.7, with 59199 shares changing hands.
Over the course of 52 weeks, the stock peaked at 3119.5 and hit a low of 2388.4.

Technicals

Support and Resistance: The price of 2822.7 is supported at 2734.5 and capped by resistance at 2949.2. These levels mark key points for Ajanta Pharma Limited where the price could find stability, with 2734.5 as a floor and 2949.2 as a ceiling.
AJANTPHARM supportResistance b52b01
Support/Resistance for AJANTPHARM


Aroon: The current reading of the AROON is neutral for AJANTPHARM, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
AJANTPHARM aroon b52b01
Aroon chart for Ajanta Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
AJANTPHARM bbands b52b01
Bolinger Bands chart for Ajanta Pharma Limited


Parabolic SAR: The PSAR maintains its bearish stance, setting a strong resistance level that could limit any potential upward movement. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult to achieve significant gains for Ajanta Pharma Limited.
AJANTPHARM psar b52b01
Parabolic Stop and Reverse chart for Ajanta Pharma Limited


Stochastic: The STOCHASTIC is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
AJANTPHARM stoch b52b01
Stochastic chart for Ajanta Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
AJANTPHARM trippleSMA b52b01
Tripple SMA chart for Ajanta Pharma Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.